Differentiated MDM were infected for 4 h and treated 1 h prior to or 4 h after HIV-1 infection with CT04 (1 μg/ml) and NSC (75 μM), RhoA or Rac1 GTPase inhibitors, respectively. The gene discussed is RHOA; the disease is HIV-1 infection.